Takahiro Anzai

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Monoclonal Antibody

Replacement Therapy

Top Venues

Pharmaceuticals (Basel, Switzerland)

Nature communications

National Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Center

Japan

Project Researcher :: Exploratory Oncology Research & Clinical Trial Center

Aichi Institute of Technology

Japan

Lecturer (part-time) :: Department of Applied Chemistry

Okazaki Institute for Integrative Bioscience

Japan

Researcher :: Department of Bioorganization Research

Publications

Kenji Takashima, Yoshikatsu Koga, Takahiro Anzai, Kayo Migita, Toru Yamaguchi, Akihiro Ishikawa, Shingo Sakashita, Masahiro Yasunaga, Tomonori Yano
Evaluation of Fluorescence Intensity and Antitumor Effect Using Real-Time Imaging in Photoimmunotherapy. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Takahiro Anzai, Shinji Saijou, Hiroki Takashima, Misato Hara, Shingo Hanaoka, Yasuhiro Matsumura, Masahiro Yasunaga
Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody-Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Hirokazu Yagi, Maho Yagi-Utsumi, Rena Honda, Yusaku Ohta, Taiki Saito, Miho Nishio, Satoshi Ninagawa, Kousuke Suzuki, Takahiro Anzai, Yukiko Kamiya, Kazuhiro Aoki, Mahito Nakanishi, Tadashi Satoh, Koichi Kato
Improved secretion of glycoproteins using an N-glycan-restricted passport sequence tag recognized by cargo receptor. Nature communications 11 (1) (2020)